Back to search
Intralesional Infusion of Lymphokine-activated Killer (LAK) Cells and Recombinant Interleukin-2 (rIL-2) for the Treatment of Patients with Malignant Brain Tumor
Data up to Jan 2025
Published1988
Citations93
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...